User profiles for Pamela J Goodwin
Pamela GoodwinMount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute at University of … Verified email at sinaihealth.ca Cited by 31327 |
[HTML][HTML] The effect of group psychosocial support on survival in metastatic breast cancer
PJ Goodwin, M Leszcz, M Ennis… - … England Journal of …, 2001 - Mass Medical Soc
Background Supportive–expressive group therapy has been reported to prolong survival
among women with metastatic breast cancer. However, in recent studies, various psychosocial …
among women with metastatic breast cancer. However, in recent studies, various psychosocial …
[PDF][PDF] Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study
PJ Goodwin, M Ennis, KI Pritchard… - Journal of clinical …, 2002 - academia.edu
Purpose: Insulin, a member of a family of growth factors that includes insulin-like growth factor
(IGF)-I and IGF-II, exerts mitogenic effects on normal and malignant breast epithelial cells, …
(IGF)-I and IGF-II, exerts mitogenic effects on normal and malignant breast epithelial cells, …
Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer
PJ Goodwin, M Ennis, KI Pritchard, J Koo… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Vitamin D has been linked to breast cancer risk, but prognostic effects are unknown.
Such effects are biologically plausible given the presence of vitamin D receptors in breast …
Such effects are biologically plausible given the presence of vitamin D receptors in breast …
Risk of menopause during the first year after breast cancer diagnosis
PJ Goodwin, M Ennis, KI Pritchard… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: Premenopausal women with breast cancer often enter a premature menopause
during initial treatment of their malignancy, with resulting loss of childbearing capacity, onset …
during initial treatment of their malignancy, with resulting loss of childbearing capacity, onset …
[HTML][HTML] Understanding the benefit of metformin use in cancer treatment
RJO Dowling, PJ Goodwin, V Stambolic - BMC medicine, 2011 - Springer
Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes.
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …
Prognostic factors in osteosarcoma: a critical review.
AM Davis, RS Bell, PJ Goodwin - Journal of Clinical Oncology, 1994 - ascopubs.org
PURPOSE The purpose of this critical appraisal was to determine the prognostic factors that
influence survival in patients with nonmetastatic, high-grade osteosarcoma of the extremities…
influence survival in patients with nonmetastatic, high-grade osteosarcoma of the extremities…
Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis
PJ Goodwin, M Ennis, KI Pritchard… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: Weight gain is common during the first year after breast cancer diagnosis. In this
study, we examined clinical factors associated with body size at diagnosis and weight gain …
study, we examined clinical factors associated with body size at diagnosis and weight gain …
Metformin in cancer: translational challenges.
…, S Niraula, V Stambolic, PJ Goodwin - Journal of molecular …, 2012 - europepmc.org
The anti-diabetic drug metformin is rapidly emerging as a potential anti-cancer agent.
Metformin, effective in treating type 2 diabetes and the insulin resistance syndromes, improves …
Metformin, effective in treating type 2 diabetes and the insulin resistance syndromes, improves …
[PDF][PDF] Obesity and breast cancer prognosis: evidence, challenges, and opportunities
S Jiralerspong, PJ Goodwin - Journal of Clinical Oncology, 2016 - clf1.medpagetoday.com
Methods We reviewed the literature regarding overweight and obesity and breast cancer
survival outcomes, overall and with regard to breast cancer subtypes, breast cancer therapies, …
survival outcomes, overall and with regard to breast cancer subtypes, breast cancer therapies, …
Insulin and related factors in premenopausal breast cancer risk
…, G McKeown-Eyssen, D Page, PJ Goodwin - Breast cancer research …, 1998 - Springer
Background: Insulin and insulin-like growth factor I (IGF-I) are important mitogens in vitro
and in vivo. It has been hypothesized that these factors may play an important role in the …
and in vivo. It has been hypothesized that these factors may play an important role in the …